As health­care heats up on HKEX, Qim­ing sets up $500M fund ded­i­cat­ed to pub­lic com­pa­nies

Since its found­ing in 2006, the part­ners at Qim­ing have built a rep for them­selves as pre­scient ven­ture in­vestors, of­fer­ing cap­i­tal to star­tups like Zai Lab at a time when it was far from cer­tain whether Chi­na’s nascent bio­phar­ma in­dus­try would ever take off.

But it did, and now Qim­ing has gath­ered $500 mil­lion to branch out.

The VC firm is now launch­ing a pub­lic eq­ui­ties unit dubbed Springhill Fund, which will in­vest in list­ed com­pa­nies in a va­ri­ety of health­care sub­sec­tors with an ini­tial re­gion­al fo­cus in Greater Chi­na and Asia, End­points News has learned.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.